Impaired Sociability of the Balb/c Mouse, an Animal Model of Autism Spectrum Disorders, is Attenuated by NMDA Receptor Agonist Interventions: Clinical Implications

作者: Stephen I. , Jessica A. , Maria R. , Amy L. , Erin E.

DOI: 10.5772/18613

关键词:

摘要: Impaired sociability is a domain of psychopathology that contributes significantly to the functional disability and poor quality life persons with Autism Spectrum Disorders (ASDs) (Brodkin, 2007; Crawley, 2004, Deutsch et al., 2011). Although cognitive functioning may influence expression impaired sociability, relationship between deficits not linear one; thus, for example, ASDs whose IQs are in near-normal above normal range manifest profound similar those shown by intellectual (Noterdaeme 2010). Currently, there no approved medications primary target sociability. The N-methyl-D-aspartic acid (NMDA) receptor an example glutamate-gated ion channel comprised four (or possibly five) constituent polypeptide subunits; it located both preand postsynaptically (Millian, 2005). Each integral membrane protein has external, transmembranous internal domains. polypeptides align themselves within lipid bilayer create potential channel, opening depends on binding L-glutamate glycine. duration frequency opening, which results calcium conductance depolarization, highly regulated. properties this ligand-gated influenced genetically combinatorial diversity subunits (i.e., insertion specific their splice variants can affect properties); allosteric modulatory ligands (e.g., neurosteroids) (Deutsch 1992); extent glycosylated nitrosylated; phosphorylated (Marino & Conn, 2002). phosphorylation state cross-talk signaling pathways NMDA receptor; stimulation metabotropic glutamate receptors co-localized cell surface (Conn 2009a; Marino When

参考文章(50)
Stephen I. Deutsch, Jessica A. Burket, Luis F. Jacome, William R. Cannon, Amy L. Herndon, d-Cycloserine improves the impaired sociability of the Balb/c mouse Brain Research Bulletin. ,vol. 84, pp. 8- 11 ,(2011) , 10.1016/J.BRAINRESBULL.2010.10.006
Katrice D. Long, John Mastropaolo, Richard B. Rosse, Kebreten F. Manaye, Stephen I. Deutsch, Modulatory effects of D-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain Brain Research Bulletin. ,vol. 69, pp. 626- 630 ,(2006) , 10.1016/J.BRAINRESBULL.2006.03.007
Jacqueline N. Crawley, Designing mouse behavioral tasks relevant to autistic-like behaviors. Mental Retardation and Developmental Disabilities Research Reviews. ,vol. 10, pp. 248- 258 ,(2004) , 10.1002/MRDD.20039
Roberto Toro, Marina Konyukh, Richard Delorme, Claire Leblond, Pauline Chaste, Fabien Fauchereau, Mary Coleman, Marion Leboyer, Christopher Gillberg, Thomas Bourgeron, None, Key role for gene dosage and synaptic homeostasis in autism spectrum disorders Trends in Genetics. ,vol. 26, pp. 363- 372 ,(2010) , 10.1016/J.TIG.2010.05.007
Jessica A. Burket, William R. Cannon, Luis F. Jacome, Stephen I. Deutsch, MK-801, a noncompetitive NMDA receptor antagonist, elicits circling behavior in the genetically inbred Balb/c mouse strain Brain Research Bulletin. ,vol. 83, pp. 337- 339 ,(2010) , 10.1016/J.BRAINRESBULL.2010.08.014
Luis F. Jacome, Jessica A. Burket, Amy L. Herndon, Stephen I. Deutsch, d-Cycloserine enhances social exploration in the Balb/c mouse Brain Research Bulletin. ,vol. 85, pp. 141- 144 ,(2011) , 10.1016/J.BRAINRESBULL.2011.03.004
Karen J. Gregory, Elizabeth N. Dong, Jens Meiler, P. Jeffrey Conn, Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential Neuropharmacology. ,vol. 60, pp. 66- 81 ,(2011) , 10.1016/J.NEUROPHARM.2010.07.007
Luis F. Jacome, Jessica A. Burket, Amy L. Herndon, William R. Cannon, Stephen I. Deutsch, D-serine improves dimensions of the sociability deficit of the genetically-inbred Balb/c mouse strain Brain Research Bulletin. ,vol. 84, pp. 12- 16 ,(2011) , 10.1016/J.BRAINRESBULL.2010.10.010
Viviane Labrie, Tatiana Lipina, John C. Roder, Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology. ,vol. 200, pp. 217- 230 ,(2008) , 10.1007/S00213-008-1196-6